Related Experiment Video
Updated: Jul 4, 2025

09:52
DNA-barcode-based Multiplex Immunofluorescence Imaging to Analyze FFPE Specimens from Genetically Reprogrammed Murine Melanoma
Published on: June 6, 2025
195
Immune subtyping of melanoma whole slide images using multiple instance learning
Lucy Godson1, Navid Alemi1, Jérémie Nsengimana2
1School of Computing, University of Leeds, Woodhouse, Leeds, LS2 9JT, United Kingdom.
Medical Image Analysis
|February 7, 2024
Summary
Deep learning models can classify melanoma immune subtypes from standard pathology slides, bypassing costly genetic tests. This approach aids in identifying prognostic markers and stratifying patients for better melanoma treatment outcomes.
Area of Science:
- Computational pathology
- Artificial intelligence in oncology
- Digital pathology image analysis
Background:
- Melanoma patient outcomes depend on early prognostic markers and treatment stratification.
- Tumor transcriptome analysis identifies immune subgroups linked to survival but is costly and not routine.
- Current clinical workflows lack efficient methods for immune profiling of melanoma tumors.
Purpose of the Study:
- To develop and validate deep learning models for classifying melanoma immune subgroups using routine histopathology slides.
- To overcome the limitations of transcriptome analysis by utilizing readily available hematoxylin and eosin (H&E) stained slides.
- To establish a cost-effective and clinically applicable method for melanoma patient stratification.
Main Methods:
- Systematic assessment of six multiple instance learning (MIL) frameworks.
- Evaluation across five image resolutions and three feature extraction methods.
- Development of pathology-specific self-supervised models for gigapixel H&E slide classification.
Main Results:
- Pathology-specific self-supervised models at 10x resolution achieved superior immune subtype classification.
- Achieved mean AUC of 0.80 in a primary melanoma dataset and 0.82 in a TCGA dataset for 'high' vs 'low' immune classification.
- Successfully stratified patients into distinct survival groups (log rank test, P<0.005) based on immune status.
Conclusions:
- Deep learning on H&E slides offers a viable alternative to transcriptome analysis for melanoma immune profiling.
- MIL methods can identify novel biomarkers and assist clinicians in inferring tumor immune landscape.
- This approach enables patient stratification for improved melanoma treatment strategies without additional genetic testing.

